Anebulo Pharmaceuticals I... (ANEB)
NASDAQ: ANEB
· Real-Time Price · USD
2.51
0.07 (2.87%)
At close: Aug 15, 2025, 3:59 PM
2.50
-0.40%
After-hours: Aug 15, 2025, 04:10 PM EDT
Anebulo Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -8.23M | -8M | -8.18M | -8.31M | -9.46M | -10.66M | -11.71M | -11.78M | -11.61M | -10.63M | -7.89M | -6.83M | -6.99M | -5.66M | -4.92M | -3.61M | -1.3M | -750K | -425K |
Interest Income | 185.55K | 151.38K | 219.83K | 249.02K | 198.81K | 209.88K | 143.17K | 87.97K | 89.9K | 10.74K | 1.93K | 1.93K | 1.02K | 1.02K | 1.02K | 1.02K | n/a | n/a | n/a |
Pretax Income | -7.69M | -7.67M | -7.92M | -8.2M | -9.35M | -10.49M | -11.6M | -11.73M | -11.56M | -10.64M | -7.88M | -6.82M | -33.61M | -32.29M | -31.55M | -30.25M | -1.32M | -760K | -431K |
Net Income | -7.69M | -7.67M | -7.92M | -8.2M | -9.35M | -10.49M | -11.62M | -11.75M | -11.57M | -10.65M | -7.88M | -6.82M | -33.61M | -32.29M | -31.55M | -30.25M | -1.32M | -760K | -431K |
Selling & General & Admin | 4.59M | 4.25M | 4.58M | 4.76M | 4.96M | 5.82M | 6.07M | 6.18M | 6.31M | 5.5M | 4.42M | 3.87M | 3.34M | 2.66M | 1.95M | 1.34M | 689.09K | 410K | 255.41K |
Research & Development | 3.64M | 3.75M | 3.59M | 3.55M | 4.5M | 4.84M | 5.65M | 5.6M | 5.3M | 5.13M | 3.47M | 2.96M | 3.65M | 3.01M | 2.97M | 2.27M | 613.31K | 340.27K | 170.29K |
Other Expenses | n/a | 2.32K | 1.73K | 9.38K | 8.19K | 5.87K | -7.37K | -14.81K | -12.8K | -9.65K | 2.31K | 2.1K | -60 | -3.21K | -1.34K | -1.34K | n/a | n/a | n/a |
Operating Expenses | 8.23M | 8M | 8.18M | 8.31M | 9.46M | 10.66M | 11.71M | 11.78M | 11.61M | 10.63M | 7.89M | 6.83M | 6.99M | 5.66M | 4.92M | 3.61M | 1.3M | 750.27K | 425.7K |
Interest Expense | 424.27K | 238.78K | 210.93K | 151.23K | 143.99K | 84.29K | 52.45K | 52.45K | 1.93K | 1.93K | 3.8K | 3.8K | 1.87K | 5.57K | 3.7K | 3.7K | 4.99K | 1.29K | 1.29K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.34M | 8M | 8.18M | 8.31M | 9.46M | 10.66M | 11.71M | 11.78M | 11.61M | 10.63M | 7.89M | 6.83M | 6.99M | 5.66M | 4.92M | 3.61M | 956.05K | 403.92K | 79.35K |
Income Tax Expense | n/a | n/a | -2.76K | -2.76K | -2.76K | -2.76K | 13.83K | 13.83K | 9.16K | 6.01K | -5.96K | -5.96K | -2.3K | 849.00 | -1.02K | -1.02K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 27.41M | 27.41M | 25.93M | 25.82M | 25.93M | 25.79M | 25.63M | 25.07M | 25.63M | 25.63M | 23.42M | 23.34M | 23.34M | 23.34M | 23.34M | 23.34M | 23.27M | 23.27M | 23.27M |
Shares Outstanding (Diluted) | 27.41M | 27.41M | 25.93M | 25.82M | 25.93M | 25.79M | 25.63M | 25.07M | 25.63M | 25.63M | 23.42M | 23.34M | 23.34M | 23.34M | 23.34M | 23.34M | 23.27M | 23.27M | 23.27M |
EPS (Basic) | -0.27 | -0.29 | -0.31 | -0.32 | -0.37 | -0.42 | -0.46 | -0.47 | -0.47 | -0.44 | -0.34 | -0.29 | -1.78 | -2.08 | -2.05 | -2 | -0.41 | -0.03 | -0.02 |
EPS (Diluted) | -0.29 | -0.29 | -0.31 | -0.32 | -0.37 | -0.42 | -0.46 | -0.47 | -0.47 | -0.44 | -0.34 | -0.29 | -1.78 | -2.08 | -2.05 | -2 | -0.41 | -0.03 | -0.02 |
EBITDA | -7.26M | -7.43M | -7.71M | -8.05M | -9.25M | -10.46M | -11.59M | -11.72M | -9.22M | -8.3M | -5.56M | -4.5M | -33.62M | -32.29M | -31.22M | -29.67M | -733.07K | -181.07K | -177.03K |
EBIT | -7.26M | -7.43M | -7.71M | -8.05M | -9.26M | -10.46M | -11.6M | -11.73M | -11.56M | -10.64M | -7.88M | -6.83M | -33.62M | -32.29M | -31.54M | -30.24M | -1.3M | -750K | -425K |
Depreciation & Amortization | 2.21M | 1.99M | 1.99M | 4.26M | 6.7M | 5.11M | 8.92M | 8.99M | 8.82M | 10.63M | 7.89M | 6.83M | 6.99M | 5.66M | 4.92M | 3.61M | 1.13M | 576.92K | 252.35K |